MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...
Scientists are addressing long-running issues over product safety, usability, and sustainability, leading to innovative ...
The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback